Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease.
Olga I AfanasievaAlexandra V TyurinaMarat V EzhovOksana A RazovaElena A KlesarevaSergei N PokrovskyPublished in: Diseases (Basel, Switzerland) (2023)
The LMW apo(a) phenotype is a risk factor for non-fatal MI in a long-term prospective follow-up of patients with premature CHD, and this link could be mediated via PCSK9.